Concepedia

Publication | Open Access

High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects

66

Citations

51

References

2018

Year

References

YearCitations

Page 1